Patents by Inventor Merika Treants KODAY

Merika Treants KODAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10766929
    Abstract: Polypeptides that bind to viral hemagglotinin are disclosed and methods for their use in treating or limiting influenza infection, and diagnosing influenza infection.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: September 8, 2020
    Assignee: University of Washington
    Inventors: David Baker, Aaron Arthur Chevalier, Gabriel Jacob Rocklin, Christopher David Bahl, Lance Joseph Stewart, Daniel Adriano Silva Manzano, Deborah L. Fuller, Merika Treants Koday, Jason Gilmore
  • Publication number: 20200017552
    Abstract: Polypeptides that bind to viral hemagglotinin are disclosed and methods for their use in treating or limiting influenza infection, and diagnosing influenza infection.
    Type: Application
    Filed: March 15, 2018
    Publication date: January 16, 2020
    Inventors: David BAKER, Aaron Arthur CHEVALIER, Gabriel Jacob ROCKLIN, Christopher David BAHL, Lance Joseph STEWART, Daniel Adriano SILVA MANZANO, Deborah L. FULLER, Merika TREANTS KODAY, Jason GILMORE
  • Patent number: 9771395
    Abstract: Designed polypeptides having the amino acid sequence of SEQ ID NQ: 1 are described that bind with high affinity and selectivity to the influenza hemagglutinin protein, and which can be used for treating and/or limiting an influenza infection, as well as diagnosing an influenza infection and identifying candidate compounds for treating an influenza infection.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: September 26, 2017
    Assignee: University of Washington
    Inventors: Merika Treants Koday, Deborah L. Fuller, Aaron Chevalier, Jorgen Nelson, David Baker
  • Publication number: 20170073375
    Abstract: Designed polypeptides having the amino acid sequence of SEQ ID NQ: 1 are described that bind with high affinity and selectivity to the influenza hemagglutinin protein, and which can be used for treating and/or limiting an influenza infection, as well as diagnosing an influenza infection and identifying candidate compounds for treating an influenza infection.
    Type: Application
    Filed: March 20, 2015
    Publication date: March 16, 2017
    Inventors: Merika Treants KODAY, Deborah L. FULLER, Aaron CHEVALIER, Jorgen NELSON, David BAKER